| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy
|
Molica, Stefano
|
|
2016
|
50 |
C |
p. 31-36
6 p.
|
artikel
|
| 2 |
Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents
|
Kim, Chan Kyu
|
|
2016
|
50 |
C |
p. 21-28
8 p.
|
artikel
|
| 3 |
Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands
|
Blommestein, Hedwig M.
|
|
2016
|
50 |
C |
p. 37-45
9 p.
|
artikel
|
| 4 |
Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia
|
Kost, Sara E.F.
|
|
2016
|
50 |
C |
p. 63-71
9 p.
|
artikel
|
| 5 |
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?
|
Nakaya, Aya
|
|
2016
|
50 |
C |
p. 46-49
4 p.
|
artikel
|
| 6 |
Deletion 5q is frequent in myelodysplastic syndrome (MDS) patients diagnosed with interstitial lung diseases (ILD): Mayo Clinic experience
|
Nanah, Rama
|
|
2016
|
50 |
C |
p. 112-115
4 p.
|
artikel
|
| 7 |
Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide
|
Chen, Jing
|
|
2016
|
50 |
C |
p. 116-122
7 p.
|
artikel
|
| 8 |
DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas
|
Ouyang, Yu
|
|
2016
|
50 |
C |
p. 104-111
8 p.
|
artikel
|
| 9 |
Editorial board and publication information
|
|
|
2016
|
50 |
C |
p. IFC-
1 p.
|
artikel
|
| 10 |
Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia
|
Visani, G.
|
|
2016
|
50 |
C |
p. 50-56
7 p.
|
artikel
|
| 11 |
Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia
|
Lou, Yinjun
|
|
2016
|
50 |
C |
p. 11-16
6 p.
|
artikel
|
| 12 |
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
|
Swords, Ronan T.
|
|
2016
|
50 |
C |
p. 123-131
9 p.
|
artikel
|
| 13 |
Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia
|
Lee, Na Hee
|
|
2016
|
50 |
C |
p. 57-62
6 p.
|
artikel
|
| 14 |
New evidence of gene inactivation by aberrant DNA-Methylation in T-cell leukemia, with treatment implications
|
Kyrtsonis, Marie-Christine
|
|
2016
|
50 |
C |
p. 29-30
2 p.
|
artikel
|
| 15 |
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli
|
Söderlund, Stina
|
|
2016
|
50 |
C |
p. 95-103
9 p.
|
artikel
|
| 16 |
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia
|
Shimizu, Ryo
|
|
2016
|
50 |
C |
p. 85-94
10 p.
|
artikel
|
| 17 |
Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome
|
Wang, Chen
|
|
2016
|
50 |
C |
p. 78-84
7 p.
|
artikel
|
| 18 |
Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine
|
Sabnis, Himalee S.
|
|
2016
|
50 |
C |
p. 132-140
9 p.
|
artikel
|
| 19 |
The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia
|
Leclerc, Gilles M.
|
|
2016
|
50 |
C |
p. 1-10
10 p.
|
artikel
|
| 20 |
The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
|
Horvat, Troy Z.
|
|
2016
|
50 |
C |
p. 17-20
4 p.
|
artikel
|
| 21 |
TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia
|
Hong, Ming
|
|
2016
|
50 |
C |
p. 72-77
6 p.
|
artikel
|
Tijdschrift beschrijving